Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jim Cramer - Mad Money
AbiomedABMDBUYMar 28, 2022
Medical device-makers are safe in a weakening economy. Shares have soared over the past 12 years by 1,350%. The pandemic caused a big delay in surgeries, but it's now time for ABMD to shine. Their products (treating heart disease) are in high demand. Their most recent quarter was really good. True, this stock isn't cheap, but not neither are their peers.
Jim Cramer - Mad MoneyUnknown
$321.81
Stock price when the opinion was issued
$381.02
As of Dec 21, 2022. Market Open.
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
